Alnylam Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 02/13/2025 | 16.60 M | $3.91 B | 0.56% | 12.91% |
| FMR LLC | 02/13/2025 | 13.49 M | $3.17 B | -8.09% | 10.49% |
| VANGUARD GROUP INC | 02/11/2025 | 12.73 M | $3.00 B | 0.78% | 9.90% |
| BLACKROCK, INC. | 02/07/2025 | 9.89 M | $2.33 B | 1.83% | 7.69% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/13/2025 | 6.97 M | $1.64 B | 32.89% | 5.42% |
| REGENERON PHARMACEUTICALS, INC. | 02/07/2025 | 4.44 M | $1.05 B | 100.00% | 3.46% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 4.38 M | $1.03 B | 39.67% | 3.41% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 4.20 M | $987.51 M | -15.28% | 3.26% |
| BAILLIE GIFFORD & CO | 01/31/2025 | 4.04 M | $950.71 M | -17.33% | 3.14% |
| DODGE & COX | 02/13/2025 | 3.54 M | $833.06 M | -2.27% | 2.75% |
| STATE STREET CORP | 02/14/2025 | 3.42 M | $805.46 M | -1.31% | 2.66% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.32 M | $781.09 M | -3.84% | 2.58% |
| NORGES BANK | 02/12/2025 | 2.46 M | $577.94 M | 100.00% | 1.91% |
| JPMORGAN CHASE & CO | 02/12/2025 | 2.25 M | $529.46 M | 4.03% | 1.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.21 M | $518.37 M | 2.78% | 1.72% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 1.60 M | $377.44 M | 0.71% | 1.25% |
| GROUPAMA ASSET MANAGMENT | 02/12/2025 | 1.53 M | $8.32 M | 0.46% | 1.19% |
| ORBIS ALLAN GRAY LTD | 02/14/2025 | 1.47 M | $346.57 M | 16.14% | 1.15% |
| CAPITAL INTERNATIONAL INVESTORS | 02/13/2025 | 1.42 M | $333.83 M | -64.27% | 1.10% |
| WINSLOW CAPITAL MANAGEMENT, LLC | 02/13/2025 | 1.02 M | $240.15 M | 6.13% | 0.79% |
| NORTHERN TRUST CORP | 02/14/2025 | 878,860 | $206.80 M | 19.59% | 0.68% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 828,917 | $195.05 M | 4.70% | 0.64% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 813,356 | $191.39 M | 60.85% | 0.63% |
| BELLEVUE GROUP AG | 02/14/2025 | 770,268 | $181.25 M | -4.80% | 0.60% |
| MORGAN STANLEY | 02/14/2025 | 727,224 | $171.12 M | 17.57% | 0.57% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 710,598 | $167.21 M | 0.62% | 0.55% |
| INVESCO LTD. | 02/13/2025 | 558,490 | $131.42 M | -19.74% | 0.43% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 556,579 | $130.97 M | 3.21% | 0.43% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 513,962 | $120.94 M | 5.46% | 0.40% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 504,038 | $118.61 M | 3.23% | 0.39% |
| LOOMIS SAYLES & CO L P | 02/12/2025 | 503,045 | $118.37 M | -4.24% | 0.39% |
| AMUNDI | 02/07/2025 | 496,301 | $119.39 M | -16.35% | 0.39% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 485,260 | $114.19 M | 218.91% | 0.38% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 479,203 | $112.76 M | 1.00% | 0.37% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 448,881 | $105.63 M | 1.77% | 0.35% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 430,612 | $101.33 M | -35.22% | 0.33% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 418,552 | $98.49 M | -24.01% | 0.33% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 415,600 | $97.79 M | 66.04% | 0.32% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 414,139 | $97.45 M | 8.14% | 0.32% |
| MARSHALL WACE, LLP | 02/13/2025 | 378,649 | $89.10 M | 496.61% | 0.29% |
| GILDER GAGNON HOWE & CO LLC | 02/14/2025 | 365,463 | $86.00 M | -4.83% | 0.28% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 363,085 | $85.44 M | 9.26% | 0.28% |
| SWISS NATIONAL BANK | 02/10/2025 | 362,600 | $85.32 M | -3.41% | 0.28% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 333,661 | $78.52 M | 10.71% | 0.26% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 333,442 | $78.46 M | 32.87% | 0.26% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 327,782 | $77.13 M | 14.78% | 0.25% |
| ROYAL BANK OF CANADA | 02/14/2025 | 310,187 | $72.99 M | -24.54% | 0.24% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 310,000 | $72.95 M | 0.00% | 0.24% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 306,455 | $72.11 M | -13.94% | 0.24% |
| UBS GROUP AG | 02/14/2025 | 289,966 | $68.23 M | 86.27% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alnylam Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 786 institutional investors and hedge funds held shares of Alnylam Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Capital World Investors: 16.6 M
FMR LLC: 13.49 M
VANGUARD GROUP INC: 12.73 M
BlackRock, Inc.: 9.89 M
Capital Research Global Investors: 6.97 M
REGENERON PHARMACEUTICALS, INC.: 4.44 M
100.70% of Alnylam Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 150.81 M shares in the last 24 months. This purchase volume represents approximately $35.55 B in transactions.